Pharmcross

Pharmcross is a South Korean contract research organization (CRO) and biotechnology company that provides comprehensive drug development services. The company specializes in clinical trial management, regulatory affairs, and pharmacovigilance for both domestic and international pharmaceutical clients. In addition to its service offerings, Pharmcross engages in the development of its own therapeutic pipeline, with lead candidates such as PX-101 for dry eye syndrome and PX-103 for atopic dermatitis. By leveraging its expertise in the Korean regulatory landscape, the company facilitates the entry of global products into the Asian market. Pharmcross is recognized for its ability to manage complex Phase I through IV trials while maintaining high standards of data integrity and statistical analysis.